{"id":9475,"date":"2020-03-16T09:52:00","date_gmt":"2020-03-16T09:52:00","guid":{"rendered":"https:\/\/ifpma.flywheelsites.com\/publications\/ifpma-note-for-guidance-on-patient-and-patient-organization-interactions\/"},"modified":"2024-06-17T11:10:41","modified_gmt":"2024-06-17T09:10:41","slug":"ifpma-note-for-guidance-on-patient-and-patient-organization-interactions","status":"publish","type":"publications","link":"https:\/\/www.ifpma.org\/publications\/ifpma-note-for-guidance-on-patient-and-patient-organization-interactions\/","title":{"rendered":"IFPMA Note for Guidance on Patient and Patient Organization Interactions"},"content":{"rendered":"<p class=\"intro\">IFPMA recognizes the work underway at the local and regional level, both within IFPMA member associations and various non-governmental organizations. Thus, the objective of this Note for Guidance is to complement existing work, and to provide additional interpretation and guidance on the provisions of Article 11 of the IFPMA Code of Practice (Interactions with Patient Organizations).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>IFPMA recognizes the work underway at the local and regional level, both within IFPMA member associations and various non-governmental organizations. Thus, the objective of this Note for Guidance is to complement existing work, and to provide additional interpretation and guidance on the provisions of Article 11 of the IFPMA Code of Practice (Interactions with Patient Organizations).<\/p>\n","protected":false},"featured_media":16140,"template":"","publication_type":[7],"topic":[29],"class_list":["post-9475","publications","type-publications","status-publish","has-post-thumbnail","hentry","publication_type-position-paper","topic-ethics"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>IFPMA Note for Guidance on Patient and Patient Organization Interactions | IFPMA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ifpma.org\/publications\/ifpma-note-for-guidance-on-patient-and-patient-organization-interactions\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IFPMA Note for Guidance on Patient and Patient Organization Interactions | IFPMA\" \/>\n<meta property=\"og:description\" content=\"IFPMA recognizes the work underway at the local and regional level, both within IFPMA member associations and various non-governmental organizations. Thus, the objective of this Note for Guidance is to complement existing work, and to provide additional interpretation and guidance on the provisions of Article 11 of the IFPMA Code of Practice (Interactions with Patient Organizations).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ifpma.org\/publications\/ifpma-note-for-guidance-on-patient-and-patient-organization-interactions\/\" \/>\n<meta property=\"og:site_name\" content=\"IFPMA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/IFPMA\/\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-17T09:10:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2020\/03\/NfG_Patient-and-Patient-Organization-Interactions.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"634\" \/>\n\t<meta property=\"og:image:height\" content=\"896\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@IFPMA\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ifpma.org\/publications\/ifpma-note-for-guidance-on-patient-and-patient-organization-interactions\/\",\"url\":\"https:\/\/www.ifpma.org\/publications\/ifpma-note-for-guidance-on-patient-and-patient-organization-interactions\/\",\"name\":\"IFPMA Note for Guidance on Patient and Patient Organization Interactions | IFPMA\",\"isPartOf\":{\"@id\":\"https:\/\/www.ifpma.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ifpma.org\/publications\/ifpma-note-for-guidance-on-patient-and-patient-organization-interactions\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ifpma.org\/publications\/ifpma-note-for-guidance-on-patient-and-patient-organization-interactions\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2020\/03\/NfG_Patient-and-Patient-Organization-Interactions.webp\",\"datePublished\":\"2020-03-16T09:52:00+00:00\",\"dateModified\":\"2024-06-17T09:10:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ifpma.org\/publications\/ifpma-note-for-guidance-on-patient-and-patient-organization-interactions\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ifpma.org\/publications\/ifpma-note-for-guidance-on-patient-and-patient-organization-interactions\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ifpma.org\/publications\/ifpma-note-for-guidance-on-patient-and-patient-organization-interactions\/#primaryimage\",\"url\":\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2020\/03\/NfG_Patient-and-Patient-Organization-Interactions.webp\",\"contentUrl\":\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2020\/03\/NfG_Patient-and-Patient-Organization-Interactions.webp\",\"width\":634,\"height\":896,\"caption\":\"Note for Guidance: Patient and Patient Organization Interactions\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ifpma.org\/publications\/ifpma-note-for-guidance-on-patient-and-patient-organization-interactions\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ifpma.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Publications\",\"item\":\"https:\/\/www.ifpma.org\/publications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"IFPMA Note for Guidance on Patient and Patient Organization Interactions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ifpma.org\/#website\",\"url\":\"https:\/\/www.ifpma.org\/\",\"name\":\"IFPMA\",\"description\":\"Innovating to improve health worldwide\",\"publisher\":{\"@id\":\"https:\/\/www.ifpma.org\/#organization\"},\"alternateName\":\"International Federation of Pharmaceutical Manufacturers and Associations\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ifpma.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ifpma.org\/#organization\",\"name\":\"IFPMA\",\"alternateName\":\"International Federation of Pharmaceutical Manufacturers and Associations\",\"url\":\"https:\/\/www.ifpma.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ifpma.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/04\/ifpma-logo-landscape-narrow.png\",\"contentUrl\":\"https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/04\/ifpma-logo-landscape-narrow.png\",\"width\":1379,\"height\":733,\"caption\":\"IFPMA\"},\"image\":{\"@id\":\"https:\/\/www.ifpma.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/IFPMA\/\",\"https:\/\/x.com\/IFPMA\",\"https:\/\/www.linkedin.com\/company\/ifpma\/\",\"https:\/\/www.youtube.com\/user\/ifpma\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IFPMA Note for Guidance on Patient and Patient Organization Interactions | IFPMA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ifpma.org\/publications\/ifpma-note-for-guidance-on-patient-and-patient-organization-interactions\/","og_locale":"en_US","og_type":"article","og_title":"IFPMA Note for Guidance on Patient and Patient Organization Interactions | IFPMA","og_description":"IFPMA recognizes the work underway at the local and regional level, both within IFPMA member associations and various non-governmental organizations. Thus, the objective of this Note for Guidance is to complement existing work, and to provide additional interpretation and guidance on the provisions of Article 11 of the IFPMA Code of Practice (Interactions with Patient Organizations).","og_url":"https:\/\/www.ifpma.org\/publications\/ifpma-note-for-guidance-on-patient-and-patient-organization-interactions\/","og_site_name":"IFPMA","article_publisher":"https:\/\/www.facebook.com\/IFPMA\/","article_modified_time":"2024-06-17T09:10:41+00:00","og_image":[{"width":634,"height":896,"url":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2020\/03\/NfG_Patient-and-Patient-Organization-Interactions.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_site":"@IFPMA","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ifpma.org\/publications\/ifpma-note-for-guidance-on-patient-and-patient-organization-interactions\/","url":"https:\/\/www.ifpma.org\/publications\/ifpma-note-for-guidance-on-patient-and-patient-organization-interactions\/","name":"IFPMA Note for Guidance on Patient and Patient Organization Interactions | IFPMA","isPartOf":{"@id":"https:\/\/www.ifpma.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ifpma.org\/publications\/ifpma-note-for-guidance-on-patient-and-patient-organization-interactions\/#primaryimage"},"image":{"@id":"https:\/\/www.ifpma.org\/publications\/ifpma-note-for-guidance-on-patient-and-patient-organization-interactions\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2020\/03\/NfG_Patient-and-Patient-Organization-Interactions.webp","datePublished":"2020-03-16T09:52:00+00:00","dateModified":"2024-06-17T09:10:41+00:00","breadcrumb":{"@id":"https:\/\/www.ifpma.org\/publications\/ifpma-note-for-guidance-on-patient-and-patient-organization-interactions\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ifpma.org\/publications\/ifpma-note-for-guidance-on-patient-and-patient-organization-interactions\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ifpma.org\/publications\/ifpma-note-for-guidance-on-patient-and-patient-organization-interactions\/#primaryimage","url":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2020\/03\/NfG_Patient-and-Patient-Organization-Interactions.webp","contentUrl":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2020\/03\/NfG_Patient-and-Patient-Organization-Interactions.webp","width":634,"height":896,"caption":"Note for Guidance: Patient and Patient Organization Interactions"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ifpma.org\/publications\/ifpma-note-for-guidance-on-patient-and-patient-organization-interactions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ifpma.org\/"},{"@type":"ListItem","position":2,"name":"Publications","item":"https:\/\/www.ifpma.org\/publications\/"},{"@type":"ListItem","position":3,"name":"IFPMA Note for Guidance on Patient and Patient Organization Interactions"}]},{"@type":"WebSite","@id":"https:\/\/www.ifpma.org\/#website","url":"https:\/\/www.ifpma.org\/","name":"IFPMA","description":"Innovating to improve health worldwide","publisher":{"@id":"https:\/\/www.ifpma.org\/#organization"},"alternateName":"International Federation of Pharmaceutical Manufacturers and Associations","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ifpma.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ifpma.org\/#organization","name":"IFPMA","alternateName":"International Federation of Pharmaceutical Manufacturers and Associations","url":"https:\/\/www.ifpma.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ifpma.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/04\/ifpma-logo-landscape-narrow.png","contentUrl":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2023\/04\/ifpma-logo-landscape-narrow.png","width":1379,"height":733,"caption":"IFPMA"},"image":{"@id":"https:\/\/www.ifpma.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/IFPMA\/","https:\/\/x.com\/IFPMA","https:\/\/www.linkedin.com\/company\/ifpma\/","https:\/\/www.youtube.com\/user\/ifpma"]}]}},"_links":{"self":[{"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/publications\/9475","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/publications"}],"about":[{"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/types\/publications"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/media\/16140"}],"wp:attachment":[{"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/media?parent=9475"}],"wp:term":[{"taxonomy":"publication_type","embeddable":true,"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/publication_type?post=9475"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/www.ifpma.org\/wp-json\/wp\/v2\/topic?post=9475"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}